<p>|Recommendations|Certainty of evidence|Evidence report(s) of the following PICO(s)|Evidence table(s), in Supp. App. 2|
|---|---|---|---|
|Oral methotrexate is conditionally recommended over subcutaneous methotrexate for patients initiating methotrexate.|Moderate|PICO 9|p. 181|